Michael Richard Dwyer Ashton

Michael Richard Dwyer Ashton

Chairman at
Komix Ltd.
79 year
Health Technology
Consumer Services
Commercial Services

Profile

Michael Richard Dwyer Ashton is currently the Chairman of Komix Ltd. He previously served as the Chief Executive Officer of SkyePharma Plc, Chairman, President & Chief Executive Officer of Faulding, Inc., Chief Executive Officer & Group President of LMA International NV, Chief Executive Officer & Executive Director of Realm Therapeutics Plc, Director of Astralis Ltd., Director of Vital Living, Inc., Director of Transition Therapeutics, Inc., Independent Non-Executive Director of Avecho Biotechnology Ltd., Director of Proximagen Group Plc, Independent Non-Executive Director of Hikma Pharmaceuticals Plc, and Managing Director of Capital Safety Group Ltd. Ashton holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from The University of Sydney.

Michael Richard Dwyer Ashton active positions

CompaniesPositionStart
Chairman -

Former positions of Michael Richard Dwyer Ashton

CompaniesPositionEnd
HIKMA PHARMACEUTICALS PLC Director/Board Member 19/05/2017
REALM THERAPEUTICS PLC Chief Executive Officer 12/06/2015
AVECHO BIOTECHNOLOGY LIMITED Director/Board Member 24/08/2010
Director/Board Member 05/10/2006
Director/Board Member 16/07/2006
See the detail of Michael Richard Dwyer Ashton's experience

Training of Michael Richard Dwyer Ashton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Producer Manufacturing

Consumer Services

Consumer Services

Retail Trade

  1. Stock Market
  2. Insiders
  3. Michael Richard Dwyer Ashton
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!